CN110914239A - 一种制备左乙拉西坦的方法 - Google Patents
一种制备左乙拉西坦的方法 Download PDFInfo
- Publication number
- CN110914239A CN110914239A CN201880044622.0A CN201880044622A CN110914239A CN 110914239 A CN110914239 A CN 110914239A CN 201880044622 A CN201880044622 A CN 201880044622A CN 110914239 A CN110914239 A CN 110914239A
- Authority
- CN
- China
- Prior art keywords
- ethyl
- oxo
- acid
- water
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004002 levetiracetam Drugs 0.000 title claims abstract description 31
- HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical compound CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000003960 organic solvent Substances 0.000 claims abstract description 20
- IODGAONBTQRGGG-LURJTMIESA-N Levetiracetam acid Chemical compound CC[C@@H](C(O)=O)N1CCCC1=O IODGAONBTQRGGG-LURJTMIESA-N 0.000 claims abstract description 18
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims abstract description 11
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 96
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 52
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- ZLKXLRFDTRFXJV-CYVRTLFJSA-N (2s)-2-(2-oxopyrrolidin-1-yl)butanoic acid;(1r)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1.CC[C@@H](C(O)=O)N1CCCC1=O ZLKXLRFDTRFXJV-CYVRTLFJSA-N 0.000 claims description 17
- 238000005886 esterification reaction Methods 0.000 claims description 16
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 claims description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 14
- 238000005915 ammonolysis reaction Methods 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- 150000007529 inorganic bases Chemical class 0.000 claims description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 238000010533 azeotropic distillation Methods 0.000 claims 1
- 238000007098 aminolysis reaction Methods 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 36
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 238000001914 filtration Methods 0.000 description 20
- 239000000126 substance Substances 0.000 description 19
- 238000001953 recrystallisation Methods 0.000 description 11
- OVLHQUWQINALPR-UHFFFAOYSA-N azane;dichloromethane Chemical compound N.ClCCl OVLHQUWQINALPR-UHFFFAOYSA-N 0.000 description 9
- 239000012065 filter cake Substances 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 238000002386 leaching Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 229910017053 inorganic salt Inorganic materials 0.000 description 7
- 238000003756 stirring Methods 0.000 description 5
- 230000032050 esterification Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 208000003078 Generalized Epilepsy Diseases 0.000 description 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000000064 cholinergic agonist Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 201000001993 idiopathic generalized epilepsy Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960004526 piracetam Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种高纯度左乙拉西坦的制备方法,包括将(S)‑α‑乙基‑2‑氧代‑1‑吡咯烷乙酸(R)‑甲基苄胺盐游离后萃取的水层调节至pH至5‑9,接着除水,再加入有机溶剂形成溶液后与氯甲酸乙酯或氯甲酸甲酯发生酯化,再进行氨解反应得到左乙拉西坦。该方法简化了生产流程,提高了收率,同时可以减少甚至避免酯化过程中三乙胺的使用,降低了大量三废的排放。
Description
PCT国内申请,说明书已公开。
Claims (11)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2017106813377 | 2017-08-10 | ||
CN201710681337.7A CN107337628B (zh) | 2017-08-10 | 2017-08-10 | 一种制备左乙拉西坦的方法 |
PCT/CN2018/099533 WO2019029598A1 (zh) | 2017-08-10 | 2018-08-09 | 一种制备左乙拉西坦的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110914239A true CN110914239A (zh) | 2020-03-24 |
CN110914239B CN110914239B (zh) | 2023-07-25 |
Family
ID=60217329
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710681337.7A Active CN107337628B (zh) | 2017-08-10 | 2017-08-10 | 一种制备左乙拉西坦的方法 |
CN201880044622.0A Active CN110914239B (zh) | 2017-08-10 | 2018-08-09 | 一种制备左乙拉西坦的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710681337.7A Active CN107337628B (zh) | 2017-08-10 | 2017-08-10 | 一种制备左乙拉西坦的方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US11498897B2 (zh) |
EP (1) | EP3666756B1 (zh) |
CN (2) | CN107337628B (zh) |
WO (1) | WO2019029598A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107337628B (zh) * | 2017-08-10 | 2022-02-08 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85105301A (zh) * | 1984-05-15 | 1987-01-14 | 尤西比公司 | (S)-α-乙基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
CN101333180A (zh) * | 2007-06-29 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦中间体的方法 |
CN107337628A (zh) * | 2017-08-10 | 2017-11-10 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2488325C (en) * | 2004-11-22 | 2010-08-24 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
CN101270070A (zh) * | 2008-05-12 | 2008-09-24 | 上海华理生物医药有限公司 | 一种高光学纯度(S)-α-乙基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
CN101885696A (zh) * | 2009-05-14 | 2010-11-17 | 上海华理生物医药有限公司 | 一种合成高纯度左乙拉西坦的方法 |
CN102863370A (zh) * | 2012-10-12 | 2013-01-09 | 上海华理生物医药有限公司 | 一种抗癫痫药左乙拉西坦的新合成方法 |
CN106748950B (zh) * | 2017-01-13 | 2019-09-03 | 成都美域高制药有限公司 | 一种布瓦西坦及其中间体的制备方法 |
-
2017
- 2017-08-10 CN CN201710681337.7A patent/CN107337628B/zh active Active
-
2018
- 2018-08-09 CN CN201880044622.0A patent/CN110914239B/zh active Active
- 2018-08-09 EP EP18843108.4A patent/EP3666756B1/en active Active
- 2018-08-09 US US16/638,105 patent/US11498897B2/en active Active
- 2018-08-09 WO PCT/CN2018/099533 patent/WO2019029598A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85105301A (zh) * | 1984-05-15 | 1987-01-14 | 尤西比公司 | (S)-α-乙基-2-氧代-1-吡咯烷乙酰胺的制备方法 |
CN101333180A (zh) * | 2007-06-29 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦中间体的方法 |
CN107337628A (zh) * | 2017-08-10 | 2017-11-10 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦的方法 |
Also Published As
Publication number | Publication date |
---|---|
US11498897B2 (en) | 2022-11-15 |
US20200172479A1 (en) | 2020-06-04 |
CN107337628A (zh) | 2017-11-10 |
EP3666756A1 (en) | 2020-06-17 |
WO2019029598A1 (zh) | 2019-02-14 |
EP3666756B1 (en) | 2022-08-03 |
CN107337628B (zh) | 2022-02-08 |
CN110914239B (zh) | 2023-07-25 |
EP3666756A4 (en) | 2020-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108658858B (zh) | 一种羟氯喹的制备和精制方法及其硫酸盐的制备方法 | |
CN109824532B (zh) | 一种合成n,n,n’,n’-四辛基-3-氧戊二酰胺的新工艺 | |
EA015967B1 (ru) | Способ получения производного бензимидазола | |
TW201429924A (zh) | 經精製之胺化合物的製造方法 | |
CN110914239A (zh) | 一种制备左乙拉西坦的方法 | |
EP3063135A1 (en) | Process for the preparation of enzalutamide | |
CN101522605B (zh) | 分离4-甲酰基苯甲酸甲酯和对苯二甲酸二甲酯的方法 | |
JP3110459B2 (ja) | p−アミノフェノール組成物の精製及びN−アセチル−p−アミノフェノールへの直接転化 | |
HRP20030438A2 (en) | A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid | |
CN109956884A (zh) | 一种苄氧胺盐酸盐的制备方法 | |
CN109879780B (zh) | 一种(2-甲胺-乙基)-氨基甲酸叔丁酯的制备方法 | |
CN107445856B (zh) | 一种n-异丙基丙烯酰胺的合成工艺 | |
JP2007332050A (ja) | 光学活性N−tert−ブチルカルバモイル−L−tert−ロイシンの製造方法 | |
EP3510016B1 (en) | Process for the production of n-boc-2-amino-3,3-dimethylbutyric acid | |
JPH082848B2 (ja) | 4−ニトロソジフェニルアミン類の製造法 | |
CN107698589A (zh) | 一种阿德呋啉的制备新方法 | |
CN107935876B (zh) | 一种2-(3-氨基-4-氯苯甲酰)苯甲酸的制备方法 | |
EP3178815B1 (en) | Method for producing optically active 2-methylpiperazine | |
JPH0971576A (ja) | カルボン酸類またはそのエステル類の製造法 | |
CN110606833A (zh) | 一种3-(3-芳基丙炔酰基)恶唑烷-2-酮及其制备方法 | |
JP2656717B2 (ja) | N−スクシンイミジル−2−キノリンカルボキシレートの製造方法 | |
CN111518131A (zh) | 一种高纯度奥利司他中间体的制备方法 | |
CA2331969A1 (en) | Process for the manufacture of a sulfenimide | |
CN104030996B (zh) | 一种缬沙坦的合成方法 | |
CN116120395A (zh) | 一种奈玛特韦中间体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |